Journal article
Prophylactic Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor Decrease Febrile Neutropenia After Chemotherapy in Children With Cancer: A Meta-Analysis of Randomized Controlled Trials
Abstract
PURPOSE: To determine whether prophylactic hematopoietic colony-stimulating factors (CSFs) used in children with cancer reduce the rate of febrile neutropenia, hospitalization duration, documented infection rate, parenteral antibiotic duration, amphotericin B use, or infection-related mortality.
METHODS: We included studies in this meta-analysis if their populations consisted of children, if there was randomization between CSFs and placebo or …
Authors
Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR
Journal
Journal of Clinical Oncology, Vol. 22, No. 16, pp. 3350–3356
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
August 15, 2004
DOI
10.1200/jco.2004.09.106
ISSN
0732-183X
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AdolescentAmphotericin BAnti-Bacterial AgentsAntineoplastic Combined Chemotherapy ProtocolsChildChild, PreschoolFemaleFeverGranulocyte Colony-Stimulating FactorGranulocyte-Macrophage Colony-Stimulating FactorHumansInfantInfant, NewbornInfectionsLength of StayMaleNeoplasmsNeutropeniaPlacebosRandomized Controlled Trials as TopicTreatment Outcome